Novel APLNR antagonist candesartan induces tumor vascular normalization through ROS/cGAS/STING axis and augmented sunitinib response in breast cancer.

J Exp Clin Cancer Res · 2025 · PMC12763877 · PMID 41316451

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Firstly, in a zebrafish retinal vascular abnormality model, where candesartan showed a trend towards normalizing the vasculature.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.